Sign In
Buy ADPT
$22.57
-1.61 (-6.66%)
At Close: Jul 31, 2026
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
04:05pm, Tuesday, 02'nd Apr 2024
SEATTLE, April 02, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune sys
The 7 Best Penny Stocks to Buy in Q2 2024
04:30pm, Wednesday, 27'th Mar 2024
This month in March is a great time to pick up shares in these best penny stocks to buy. I chose the companies due to their strong fundamentals and potential for significant upside.
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
08:30am, Wednesday, 27'th Mar 2024
SEATTLE, March 27, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune sys
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
04:05pm, Thursday, 22'nd Feb 2024
SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune syst
Adaptive Biotechnologies Corporation (ADPT) Q4 2023 Earnings Call Transcript
09:51pm, Wednesday, 14'th Feb 2024
Adaptive Biotechnologies Corporation (ADPT) Q4 2023 Earnings Call Transcript
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Wednesday, 14'th Feb 2024
SEATTLE, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the gen
Exploring Analyst Estimates for Adaptive Biotechnologies (ADPT) Q4 Earnings, Beyond Revenue and EPS
10:21am, Monday, 12'th Feb 2024
Beyond analysts' top -and-bottom-line estimates for Adaptive Biotechnologies (ADPT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performe
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
04:05pm, Monday, 29'th Jan 2024
SEATTLE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune syst
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04:05pm, Wednesday, 27'th Dec 2023
SEATTLE, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune syst
Cathie Wood Is Loading Up on These 3 Small-Cap Stocks: Should You?
05:50am, Tuesday, 12'th Dec 2023
Adaptive Biotechnologies offers services related to immunosequencing and immune medicine. Genius Sports' sports data and technology is used by more than 400 sports organizations worldwide.
SEATTLE, Dec. 09, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune syst
SEATTLE, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune syst
